E-LIB Suche - Ergebnisse für: Haelewyn, Benoit

1

Improving stroke outcomes in hyperglycemic mice by modulati..:

Lebrun, Florent ; Levard, Damien ; Lemarchand, Eloïse...
Blood Advances. 8 (2024) 5 - p. 1330-1344 , 2024

Link: https://doi.org/10.1182/..

2

Neuroendothelial NMDA receptors as therapeutic targets in e..:

Macrez, Richard ; Ortega, Maria C. ; Bardou, Isabelle...
Brain. 139 (2016) 9 - p. 2406-2419 , 2016

Link: https://doi.org/10.1093/..

3

Molecular magnetic resonance imaging discloses endothelial ..:

Quenault, Aurélien ; Martinez de Lizarrondo, Sara ; Etard, Olivier...
Brain. 140 (2016) 1 - p. 146-157 , 2016

Link: https://doi.org/10.1093/..

4

The underestimated effect of normobaric hyperoxia on cerebr..:

Chazalviel, Laurent ; David, Hélène N. ; Haelewyn, Benoit...
Brain. 139 (2016) 11 - p. e62-e62 , 2016

Link: https://doi.org/10.1093/..

5

Ex Vivo and In Vivo Neuroprotection Induced by Argon When G..:

David, Hélène N. ; Haelewyn, Benoît ; Degoulet, Mickael...
PLoS ONE. 7 (2012) 2 - p. e30934 , 2012

Link: https://doi.org/10.1371/..

6

Ultra-sensitive molecular MRI of cerebrovascular cell activ..:

Montagne, Axel ; Gauberti, Maxime ; Macrez, Richard...
NeuroImage. 63 (2012) 2 - p. 760-770 , 2012

Link: https://doi.org/10.1016/..

7

Modulation by the noble gas argon of the catalytic and thro..:

David, Hélène N. ; Haelewyn, Benoît ; Risso, Jean-Jacques.
Naunyn-Schmiedeberg's Archives of Pharmacology. 386 (2012) 1 - p. 91-95 , 2012

Link: https://doi.org/10.1007/..

8

Xenon is an Inhibitor of Tissue-Plasminogen Activator: Adve..:

David, Hélène N ; Haelewyn, Benoît ; Risso, Jean-Jacques..
Journal of Cerebral Blood Flow & Metabolism. 30 (2010) 4 - p. 718-728 , 2010

Link: https://doi.org/10.1038/..

9

Human Recombinant Tissue-Plasminogen Activator (Alteplase):..:

Haelewyn, Benoît ; Risso, Jean-Jacques ; Abraini, Jacques H
Journal of Cerebral Blood Flow & Metabolism. 30 (2010) 5 - p. 900-903 , 2010

Link: https://doi.org/10.1038/..

10

Post-Ischemic Helium Provides Neuroprotection in Rats Subje..:

David, Hélène N ; Haelewyn, Benoît ; Chazalviel, Laurent...
Journal of Cerebral Blood Flow & Metabolism. 29 (2009) 6 - p. 1159-1165 , 2009

Link: https://doi.org/10.1038/..

11

Functional (neurologic) recovery following transient focal ..:

Haelewyn, Benoit ; Rouillon, Christophe ; Risso, Jean-Jacques.
Experimental Neurology. 213 (2008) 1 - p. 238-240 , 2008

Link: https://doi.org/10.1016/..

12

NMDA-induced striatal brain damage and time-dependence reli..:

Haelewyn, Benoît ; Alix, Philippe ; Maubert, E..
Journal of Neuroscience Methods. 168 (2008) 2 - p. 479-482 , 2008

Link: https://doi.org/10.1016/..

13

Neuroprotective effects of xenon: a therapeutic window of o..:

David, Hélène N. ; Haelewyn, Benoit ; Rouillon, Christophe...
The FASEB Journal. 22 (2007) 4 - p. 1275-1286 , 2007

Link: https://doi.org/10.1096/..

14

Mechanisms of Sevoflurane-induced Myocardial Preconditionin..:

Yvon, Alexandra ; Hanouz, Jean-Luc ; Haelewyn, Benoît...
Anesthesiology. 99 (2003) 1 - p. 27-33 , 2003

Link: https://doi.org/10.1097/..

15

Efficacy of Alteplase® in a mouse model of acute ischemic s..:

Orset, Cyrille ; Haelewyn, Benoit ; Allan, Stuart M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846545/. , 2016

Link: http://www.ncbi.nlm.nih...